Davies Executive to Speak at ExL Pharma Conference
2
Contact: Brandon Edwards DAVIES 805-963-5929 office 805-698-5780 mobile [email protected] DAVIES PRACTICE LEADER MICHAEL WONG INVITED TO SPEAK AT 2009 ANNUAL ExL PHARMA PR SUMMIT SANTA BARBARA, CALIF. (July 13, 2009) – DAVIES Senior Vice-President and Pharma/Biotech Practice Leader Michael Wong, will discuss the power of cooperation between pharmaceutical and community-based organizations during a panel session at the 5 th Annual ExL Pharma Public Relations & Communications Summit on July 27, 2009 at Pfizer’s World Headquarters in New York. The session will focus on the benefits of turning the typical communications pyramid upside down, mobilizing individual consumers and their advocacy groups first. Wong will join other panelists Mark Saunders (GlaxoSmithKline, former marketing executive) and Leonard Tran (Asian Health Foundation of Southern California, executive director). The will describe a specific case study in which pharmaceutical companies and community-based organizations were able to find a common ground, work through differences, and come together to reach business and social goals to truly create a mutual win. Wong, along with these two other experts, will provide key findings from three very different perspectives – pharmaceutical, community-based non-profit, and agency – and focus on what it takes to build a successful community-based and patient-centric program. “Adopting a patient-centric, community-based approach is an innovative strategy that can be used to solve many of pharmaceutical’s current challenges – winning formulary battles, improving patient adherence and minimizing adverse events,” said Wong. “It’s important to share knowledge and lessons learned with executives about how we create such strategies and take a successful new approach to healthcare and pharma issues.” Wong leads the Pharma/Biotech Practice and oversees the creation and implementation of strategic communications for pharmaceutical and biotech clients involved in crisis, high stakes issues and key product and corporate initiatives that affect client reputation, revenue and business success. Throughout his career, Wong has helped solve the toughest business problems and reputation challenges for his clients. Wong brings more than 20 years of experience as a business and C-suite counselor for pharmaceutical and biotech clients including Novartis, GlaxoSmithKline, Bayer, Merck, Medtronic and Boehringer Ingelheim. Most recently, Wong was Healthcare Practice Leader for GCI Group. His career includes senior healthcare positions at some of the leading healthcare agencies – Fleishman Hillard and Ruder Finn – and service as Director of Public Affairs at Abbott. --more—
description
Davies Executive to Speak at ExL Pharma Conference
Transcript of Davies Executive to Speak at ExL Pharma Conference
Contact: Brandon Edwards DAVIES 805-963-5929 office 805-698-5780 mobile [email protected]
DAVIES PRACTICE LEADER MICHAEL WONG INVITED TO SPEAK AT 2009 ANNUAL ExL PHARMA PR SUMMIT
SANTA BARBARA, CALIF. (July 13, 2009) – DAVIES Senior Vice-President and Pharma/Biotech Practice Leader Michael Wong, will discuss the power of cooperation between pharmaceutical and community-based organizations during a panel session at the 5th Annual ExL Pharma Public Relations & Communications Summit on July 27, 2009 at Pfizer’s World Headquarters in New York. The session will focus on the benefits of turning the typical communications pyramid upside down, mobilizing individual consumers and their advocacy groups first. Wong will join other panelists Mark Saunders (GlaxoSmithKline, former marketing executive) and Leonard Tran (Asian Health Foundation of Southern California, executive director). The will describe a specific case study in which pharmaceutical companies and community-based organizations were able to find a common ground, work through differences, and come together to reach business and social goals to truly create a mutual win. Wong, along with these two other experts, will provide key findings from three very different perspectives – pharmaceutical, community-based non-profit, and agency – and focus on what it takes to build a successful community-based and patient-centric program. “Adopting a patient-centric, community-based approach is an innovative strategy that can be used to solve many of pharmaceutical’s current challenges – winning formulary battles, improving patient adherence and minimizing adverse events,” said Wong. “It’s important to share knowledge and lessons learned with executives about how we create such strategies and take a successful new approach to healthcare and pharma issues.” Wong leads the Pharma/Biotech Practice and oversees the creation and implementation of strategic communications for pharmaceutical and biotech clients involved in crisis, high stakes issues and key product and corporate initiatives that affect client reputation, revenue and business success. Throughout his career, Wong has helped solve the toughest business problems and reputation challenges for his clients. Wong brings more than 20 years of experience as a business and C-suite counselor for pharmaceutical and biotech clients including Novartis, GlaxoSmithKline, Bayer, Merck, Medtronic and Boehringer Ingelheim. Most recently, Wong was Healthcare Practice Leader for GCI Group. His career includes senior healthcare positions at some of the leading healthcare agencies – Fleishman Hillard and Ruder Finn – and service as Director of Public Affairs at Abbott.
--more—
A former practicing attorney, Wong is known for his smart, business-savvy thinking, strategic insight for defending corporate reputations, and for tackling thorny matters that threaten corporate and brand position. To learn more about DAVIES, please visit www.DaviesPublicAffairs.com. For more information about the 2009 ExL Pharma Public Relations and Communications Summit, visit http://www.exlpharma.com/eventDetail.php?id=173
# # # About DAVIES DAVIES ranks among the fastest growing strategic communications firms in the United States with specialized industry practice groups in Healthcare, Pharma/Biotech, Real Estate, Energy & Natural Resources, and a new Crisis Management Practice. DAVIES utilizes highly targeted grassroots and communication programs to help their clients successfully manage defining and high stakes issues. The firm employs 30 professionals in its Santa Barbara, Los Angeles, Sacramento, Chicago, and Washington D.C. offices, and can be found online at www.DaviesPublicAffairs.com.
About ExL Pharma ExL Pharma, a division of ExL Events, Inc., is an emerging leader in developing innovative, educational events that serve the healthcare community and allied professionals. Behind our diverse conference portfolio, our experienced team conducts extensive market research and targeted outreach. The results translate into innovative, high-quality conference events designed to exceed the dynamic informational needs of the healthcare community.
